A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 6,229,634 shares of CPRX stock, worth $135 Million. This represents 2.3% of its overall portfolio holdings.

Number of Shares
6,229,634
Previous 9,127,305 31.75%
Holding current value
$135 Million
Previous $141 Million 12.4%
% of portfolio
2.3%
Previous 2.97%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.19 - $21.35 $44 Million - $61.9 Million
-2,897,671 Reduced 31.75%
6,229,634 $124 Million
Q2 2024

Aug 14, 2024

SELL
$14.68 - $16.92 $51,556 - $59,423
-3,512 Reduced 0.04%
9,127,305 $141 Million
Q1 2024

May 15, 2024

BUY
$13.18 - $17.11 $3.19 Million - $4.14 Million
241,916 Added 2.72%
9,130,817 $146 Million
Q4 2023

Feb 14, 2024

BUY
$11.78 - $17.29 $8.21 Million - $12 Million
696,901 Added 8.51%
8,888,901 $149 Million
Q2 2023

Aug 14, 2023

SELL
$11.5 - $18.08 $24.9 Million - $39.1 Million
-2,163,099 Reduced 20.89%
8,192,000 $110 Million
Q1 2023

May 15, 2023

BUY
$14.34 - $21.05 $64.1 Million - $94.1 Million
4,470,651 Added 75.97%
10,355,099 $172 Million
Q4 2022

Feb 14, 2023

BUY
$12.25 - $19.5 $12.1 Million - $19.3 Million
988,448 Added 20.19%
5,884,448 $109 Million
Q3 2022

Nov 14, 2022

BUY
$7.06 - $15.52 $34.6 Million - $76 Million
4,896,000 New
4,896,000 $62.8 Million

Others Institutions Holding CPRX

About CATALYST PHARMACEUTICALS, INC.


  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.22B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Deerfield Management Company, L.P. (Series C) Portfolio

Follow Deerfield Management Company, L.P. (Series C) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.